Healthequity Inc [HQY] stock is trading at $91.42, up 0.93%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HQY shares have gain 8.32% over the last week, with a monthly amount glided 10.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on March 25, 2025, when Raymond James upgraded its rating to a Strong Buy and also revised its price target to $115 from $120. Previously, Mizuho started tracking the stock with Outperform rating on December 04, 2024, and set its price target to $126. On November 15, 2024, Goldman initiated with a Neutral rating and assigned a price target of $108 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $101 on April 04, 2024. JP Morgan reiterated its recommendation of a Overweight and raised its price target to $108 on April 02, 2024. Barclays started tracking with a Overweight rating for this stock on January 03, 2024, and assigned it a price target of $84. In a note dated September 21, 2023, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $79 to $87.
Healthequity Inc [HQY] stock has fluctuated between $65.01 and $115.59 over the past year. Currently, Wall Street analysts expect the stock to reach $112.33 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $91.42 at the most recent close of the market. An investor can expect a potential return of 22.87% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Healthequity Inc [NASDAQ:HQY] reported sales of 1.20B for the trailing twelve months, which represents a growth of 18.84%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.52.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 89.38 points at the first support level, and at 87.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.18, and for the 2nd resistance point, it is at 94.94.
Ratios To Look Out For
For context, Healthequity Inc’s Current Ratio is 3.06. Also, the Quick Ratio is 3.06, while the Cash Ratio stands at 1.89. Considering the valuation of this stock, the price to sales ratio is 6.59, the price to book ratio is 3.74 and price to earnings (TTM) ratio is 83.85.
Transactions by insiders
Recent insider trading involved SELANDER ROBERT W, Director, that happened on Apr 09 ’25 when 5750.0 shares were sold. Officer, Stephen Neeleman completed a deal on Apr 08 ’25 to buy 9019.0 shares. Meanwhile, Officer Delano Ladd bought 6991.0 shares on Apr 08 ’25.
